Zobrazeno 1 - 10
of 1 184
pro vyhledávání: '"O, Mors"'
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 33, Iss , Pp 100685- (2023)
Introduction: Inflammation has been associated with depression and differential antidepressant (AD) treatment response. Soluble urokinase plasminogen activator receptor (suPAR) is a novel measure of chronic inflammation. We investigated whether suPAR
Externí odkaz:
https://doaj.org/article/cd1ad838ee364a168105a350778acdd3
Publikováno v:
European Psychiatry, Vol 66, Pp S132-S133 (2023)
Introduction Antipsychotics (AP) are the primary pharmacological treatment for schizophrenia but increase the risk for diabetes, with recent meta-analyses indicating important differences between specific APs. However, these findings are based on ran
Externí odkaz:
https://doaj.org/article/1eebf30adfc545658e119d7b45bbd284
Publikováno v:
European Psychiatry, Vol 66, Pp S1069-S1069 (2023)
Introduction Antipsychotics (AP) are used as the primary pharmaceutical treatment for schizophrenia. Randomised clinical trials (RCT) show that the initiation of AP treatment often induces side effects such as substantial weight gain and metabolic di
Externí odkaz:
https://doaj.org/article/c72fd3ad36dc4b09a9d70a82bf54d3cf
Publikováno v:
European Psychiatry, Vol 65, Pp S766-S766 (2022)
Introduction Non-suicidal self-injury (NSSI) is intentional self-inflicted destruction of body tissue without suicidal intention, whereas deliberate self-harm (DSH) is self-inflicted destruction of body tissue regardless of intent. In clinical sample
Externí odkaz:
https://doaj.org/article/dd6c66698d8f4d598ac61b3809bace38
Publikováno v:
European Psychiatry, Vol 65, Pp S594-S594 (2022)
Introduction Non-suicidal self-injury (NSSI) is associated with emotional distress and mental disorders. In clinical samples NSSI is reported by 21% to 60% of all psychiatric patients. Developed NSSI instruments are not suitable for clinical settings
Externí odkaz:
https://doaj.org/article/38bbce557229478faee98ee6177e52ab
Identifying prodromal biomarkers for schizophrenia and bipolar disorder using magnetoencephalography
Publikováno v:
European Psychiatry, Vol 65, Pp S640-S640 (2022)
Introduction Schizophrenia (SZ) and bipolar disorder (BD) are severe mental illnesses with large overlapping heritability. Both disorders are associated with altered neurophysiological responses, as measured with magnetoencephalography (MEG) or elect
Externí odkaz:
https://doaj.org/article/1b9c01fab9cf46888065dac5279579c5
Autor:
H. C. B. Nørgaard, H. Schou Pedersen, M. Fenger-Grøn, M. Vestergaard, M. Nordentoft, T. M. Laursen, O. Mors
Publikováno v:
Scandinavian Journal of Primary Health Care, Vol 37, Iss 3, Pp 358-365 (2019)
Objective: Schizophrenia is associated with high mortality, somatic comorbidity and reduced life expectancy. The general practitioner (GP) plays a key role in the treatment of mental and physical multimorbidity. Nevertheless, it is unclear how much i
Externí odkaz:
https://doaj.org/article/54db81efeb0141cb90ad7c5ce47a8c57
Publikováno v:
European Psychiatry, Vol 64, Pp S592-S593 (2021)
Introduction The six-item Positive And Negative Syndrome Scale (PANSS-6) is short psychometric valid scale quantifying the severity of core schizophrenia symptoms. Using PANSS-6 to guide treatment decision-making requires that staff members’ rating
Externí odkaz:
https://doaj.org/article/5a345f0aa9914566bfc3d245e6a22a68
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.